See also this year's filing and all EDGAR filings for this company.
PDF Report 0001479290_2019_Revance_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001479290, Revance Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 207,922,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 14,449,000 |
| 3 | remainder_Assets | 3,977,000 |
| 4 | LiabilitiesCurrent | 31,970,000 |
| 5 | LiabilitiesNoncurrent | 42,684,000 |
| 6 | remainder_Liabilities | 6,072,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 79,891,912 |
| 9 | ResearchAndDevelopmentExpense | 101,626,748 |
| 10 | remainder_Expenses | 3,217,886 |
| 11 | remainder_Revenues | 531,418 |
| 12 | remainder_NetIncome | 2,304,208 |
| 13 | remainder_ComprehensiveNetIncome | 8,227 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 226,348,000 |
| 1 | Liabilities | 80,726,000 |
| 2 | Expenses | 184,736,546 |
| 3 | Revenues | 531,418 |
| 4 | StockholdersEquity | 145,622,000 |
| 5 | NetIncome | -181,900,920 |
| 6 | ComprehensiveNetIncome | -181,896,806 |
| 7 | BaseVar | 247,327,200 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.883 |
| 9 | EconomicCapitalRatio | 2.21 |
Edgar->Model Mapping
Feature Distribution
Change over Time
